These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 33665036)
1. Identification of the hub gene BUB1B in hepatocellular carcinoma via bioinformatic analysis and in vitro experiments. Fu J; Zhang X; Yan L; Shao Y; Liu X; Chu Y; Xu G; Xu X PeerJ; 2021; 9():e10943. PubMed ID: 33665036 [TBL] [Abstract][Full Text] [Related]
2. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
3. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma. Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549 [TBL] [Abstract][Full Text] [Related]
4. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods. Li Z; Lin Y; Cheng B; Zhang Q; Cai Y Front Genet; 2021; 12():571231. PubMed ID: 33767726 [TBL] [Abstract][Full Text] [Related]
5. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis. Yang WX; Pan YY; You CG Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652 [TBL] [Abstract][Full Text] [Related]
6. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis. Mi N; Cao J; Zhang J; Fu W; Huang C; Gao L; Yue P; Bai B; Lin Y; Meng W; Li X Oncol Lett; 2020 Aug; 20(2):1695-1708. PubMed ID: 32724412 [TBL] [Abstract][Full Text] [Related]
7. Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis. Sun Q; Liu P; Long B; Zhu Y; Liu T Medicine (Baltimore); 2020 Aug; 99(32):e21702. PubMed ID: 32769939 [TBL] [Abstract][Full Text] [Related]
8. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis. Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients. Zhuang L; Yang Z; Meng Z Biomed Res Int; 2018; 2018():7897346. PubMed ID: 30363964 [TBL] [Abstract][Full Text] [Related]
10. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases. Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537 [No Abstract] [Full Text] [Related]
11. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma]. Yu Y; Cheng J; Mei CZ; Dai YZ Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255 [TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of Hub Genes with Poor Prognosis in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis. Guo J; Li W; Cheng L; Gao X Int J Gen Med; 2022; 15():3933-3941. PubMed ID: 35431572 [TBL] [Abstract][Full Text] [Related]
13. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis. Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of abnormal expression, prognostic value and oncogenic role of the hub gene FN1 in pancreatic ductal adenocarcinoma Lei X; Chen G; Li J; Wen W; Gong J; Fu J PeerJ; 2021; 9():e12141. PubMed ID: 34567847 [TBL] [Abstract][Full Text] [Related]
15. CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis. Yang Z; Wu X; Li J; Zheng Q; Niu J; Li S Int J Gen Med; 2021; 14():10185-10194. PubMed ID: 34992437 [TBL] [Abstract][Full Text] [Related]
16. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis. Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405 [TBL] [Abstract][Full Text] [Related]
17. Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis. Wang M; Wang L; Wu S; Zhou D; Wang X Int J Genomics; 2019; 2019():3518378. PubMed ID: 31886163 [TBL] [Abstract][Full Text] [Related]
18. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
19. Identifying potential prognosis markers in hepatocellular carcinoma Hu X; Zhou J; Zhang Y; Zeng Y; Jie G; Wang S; Yang A; Zhang M Front Genet; 2022; 13():942454. PubMed ID: 35928445 [No Abstract] [Full Text] [Related]
20. Identification of hub genes associated with bladder cancer using bioinformatic analyses. Zheng W; Zhao Y; Wang T; Zhao X; Tan Z Transl Cancer Res; 2022 May; 11(5):1330-1343. PubMed ID: 35706790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]